Deferred Tax Assets, Valuation Allowance of agilon health, inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
agilon health, inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • agilon health, inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $503,962,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

agilon health, inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $503,962,000 +$75,245,000 +18% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q4 2024 $428,717,000 +$62,785,000 +17% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q4 2023 $365,932,000 +$51,766,000 +16% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $314,166,000 +$53,566,000 +21% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q4 2021 $260,600,000 +$133,700,000 +105% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q4 2020 $126,900,000 31 Dec 2020 10-K 03 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.